Oklahoma Supreme Court throws out $465 million opioid verdict against Johnson & Johnson
The Oklahoma Supreme Court on Tuesday overturned a $465 million judgement against Johnson & Johnson for its role in marketing, selling, and distributing opioids in the state. The 5-1 ruling found that Cleveland County District Judge Thad Balkman and state prosecutors had incorrectly used public nuisance laws to find Johnson & Johnson culpable in 2019.
"In reaching this decision, we do not minimize the severity of the harm that thousands of Oklahoma citizens have suffered because of opioids," the Oklahoma Supreme Court majority wrote in its ruling. "However grave the problem of opioid addiction is in Oklahoma, public nuisance law does not provide a remedy for this harm." The lone dissenter said the ruling should have been sent back to the lower court.
This is the second blow against the use of public nuisance laws against companies involved in the sale and distribution of opioids; a California judge tentatively ruled last week that several large counties had not proved opioid companies had violated public nuisance laws because they had failed to show that deceptive marketing had increased prescription abuse. Public nuisance laws are being used against opioid companies across the U.S. as states and local governments try to get restitution for an opioid crisis blamed for more than 500,000 deaths in 20 years.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Johnson & Johnson praised the Oklahoma ruling while state Attorney General John O'Connor said he was "disappointed" the Supreme Court had voided "a huge victory for Oklahoma citizens and their families who have been ravaged by opioids." He said his office will explore its options.
Are these two rulings against opioid flooding as a public nuisance "outlier opinions or are they trendsetters?" Elizabeth Burch, a University of Georgia law professor, told The Washington Post. "I think it's too early to be able to tell right now." There's a lot more opioid litigation on the horizon, she added, so "there's a lot that remains to be seen.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The best new music of 2024 by genre
The Week Recommends Outstanding albums, from pop to electro and classical
By The Week UK Published
-
Nine best TV shows of 2024 to binge this Christmas
The Week Recommends From Baby Reindeer and Slow Horses to Rivals and Shogun, here are the critics' favourites
By The Week UK Published
-
Crossword: December 28, 2024
The Week's daily crossword puzzle
By The Week Staff Published
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ADHD drugs shortage: what's behind it?
The Explainer Supply chain issues and 'tripling' of prescriptions concerns GPs as problems getting medication become 'desperate'
By The Week UK Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
Pink cocaine: the new drug cocktail responsible for an increasing number of deaths
In the Spotlight The substance has been linked to the death of Liam Payne and named in a lawsuit against Sean 'Diddy' Combs
By Justin Klawans, The Week US Published